However, our work extends beyond this foundational research by integrating machine learning algorithms to construct a prognostic gene signature, and by conducting comprehensive in vitro functional assays (including proliferation, migration, and invasion) to mechanistically validate FREM1's role in modulating tumor aggressiveness. This evidence concerns the gene FREM1 and neoplasm.